These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26762655)

  • 1. Patterns of service utilisation within Australian hepatology clinics: high prevalence of advanced liver disease.
    El-Atem NA; Wojcik K; Horsfall L; Irvine KM; Johnson T; McPhail SM; Powell EE
    Intern Med J; 2016 Apr; 46(4):420-6. PubMed ID: 26762655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis C.
    Horsfall L; Macdonald G; Scott I; Skoien R; Khatun M; Moss C; Seligman C; Kardash C; Poxon V; Powell EE
    Aust Health Rev; 2013 May; 37(2):218-22. PubMed ID: 23448666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
    Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 24-hour access outpatient clinic for patients with exacerbation of chronic disease: a before-after cohort study of differences in acute healthcare utilisation.
    Møller AD; Christiansen DH; Bell C; Fredberg U; Vedsted P
    BMC Health Serv Res; 2018 Aug; 18(1):663. PubMed ID: 30153833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nurse-led clinic: effective and efficient delivery of assessment and review of patients with hepatitis B and C.
    Biddle ML; Adler NR; Heath M; Streat S; Wardrop M; Watson JP
    Intern Med J; 2014 Jun; 44(6):581-5. PubMed ID: 24612294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver disease referrals to an urban, hospital-based hepatology outpatient clinic over the past 25 years.
    Grubert Van Iderstine M; Iluz-Freundlich D; Dolovich C; Villarin E; Minuk GY
    JGH Open; 2020 Jun; 4(3):484-489. PubMed ID: 32514458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiologic types of end-stage chronic liver disease in adults: analysis of prevalence and their temporal changes from a study on native liver explants.
    Nayak NC; Jain D; Vasdev N; Gulwani H; Saigal S; Soin A
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1199-208. PubMed ID: 22751227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Liver Disease and Utilization of a Hepatology Consultation Service at an Urban Tertiary Care Hospital.
    Wong SG; Pollock R; Minuk GY
    Clin Invest Med; 2015 Dec; 38(6):E358-61. PubMed ID: 26654518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic and Clinical Factors Associated with Nonattendance at the Hepatology Clinic.
    Rustam LB; Vander Weg M; Chrischilles E; Tanaka T
    Dig Dis Sci; 2023 Jun; 68(6):2398-2405. PubMed ID: 37106247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilisation patterns and cost of hospital care for people living with HIV in Ireland in 2012: a single-centre study.
    Brennan A; Horgan M; Jackson A; Browne JP; Bergin CJ
    Int J STD AIDS; 2017 Mar; 28(3):229-237. PubMed ID: 27000297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Referral patterns to a district general hospital gastroenterology outpatient clinic: implications for the 'two-week target'.
    Martin JP; Gabe SM; Pitcher MC; Jacyna MR
    Int J Clin Pract; 2002; 56(1):26-8. PubMed ID: 11833552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics.
    Elangovan H; Rajagopaul S; Williams SM; McKillen B; Britton L; McPhail SM; Horsfall LU; Valery PC; Hayward KL; Powell EE
    Hepatol Commun; 2020 Apr; 4(4):518-526. PubMed ID: 32258947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of alcohol histories obtained from patients with liver disease: opportunities to improve early intervention.
    Fagan KJ; Irvine KM; Kumar S; Bates A; Horsfall LU; Feeney GF; Powell EE
    Intern Med J; 2013 Oct; 43(10):1096-102. PubMed ID: 23834077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New Zealand.
    Howell J; Balderson G; Hellard M; Gow P; Strasser S; Stuart K; Wigg A; Jeffrey G; Gane E; Angus PW
    J Gastroenterol Hepatol; 2016 Feb; 31(2):434-41. PubMed ID: 26251217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specialized surveillance for individuals at high risk for melanoma: a cost analysis of a high-risk clinic.
    Watts CG; Cust AE; Menzies SW; Coates E; Mann GJ; Morton RL
    JAMA Dermatol; 2015 Feb; 151(2):178-86. PubMed ID: 25389712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up to a federally qualified health center and subsequent emergency department utilization.
    Scherer TM; Lewis LM
    Acad Emerg Med; 2010 Jan; 17(1):55-62. PubMed ID: 20078437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a chronic disease management model for patients with chronic liver failure.
    Wigg AJ; McCormick R; Wundke R; Woodman RJ
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):850-8.e1-4. PubMed ID: 23375997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
    Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
    Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Only one-third of referrals for fatty liver disease are on time: real-world study reveals opportunities to avoid unnecessary and delayed referrals.
    Lindvig KP; Wernberg CW; Kjaergaard M; Thorhauge KH; Alnor AB; Thiele M; Krag A
    Scand J Gastroenterol; 2022 Dec; 57(12):1478-1485. PubMed ID: 35793386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection.
    Gordon SC; Pockros PJ; Terrault NA; Hoop RS; Buikema A; Nerenz D; Hamzeh FM
    Hepatology; 2012 Nov; 56(5):1651-60. PubMed ID: 22610658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.